hotline no.
+91 124 4141414
About Medanta


Start Date : 20 Sep 2014                                       End Date : 21 Sep 2014
Cancer prostate the second most common cancer in males. With the increase in longevity & health awareness, the numbers of patients of cancer prostate are increasing every year. There is also stage migration and also younger men are being diagnosed with cancer prostate.
During the last 2 decades, there have been significant advances in the field of diagnosis (new molecular biomarkers, imaging, Ultrasound guided and MRI fusion biopsy,) risk stratification (for selection of best modality of treatment) and therapeutics (robotic surgery, radiation techniques, hormonal treatment, chemotherapy, immunotherapy, focal targeted therapy etc) in the management of cancer prostate.
This update is planned to cover all these aspects and share experience from National and International faculty. The program is aimed for practicing physicians, surgeons, urologists, radiation and medical oncologists and post graduate students.
We also have a half day session for open discussion with previously treated cancer prostate patients, who will share their perspectives and outcome of the treatment.
The scientific program is accredited for 12 CME hours by Haryana Medical Council.
You along with your colleagues are invited to participate in this academic program.
Contact Details
Contact Name :
Abhishek Singhal
Venue :
2nd Floor, Auditorium, Medanta - The Medicity
Phone :
99716 98170
Email :
Find a Doctor

This is content box Three
Newsletter Subscription